Migraine headache treatment Treximet, developed by pharmaceutical company Pozen (NASDAQ:POZN), has won a patent victory against generics companies looking to introduce their versions of the drug. A federal judge in Texas has ruled that two Treximet patents are valid and enforceable, and were infringed by Par Pharmaceutical (NYSE:PRX), Alphapharm and Dr. Reddy’s Laboratories (NYSE:RDY). A […]
New osteoarthritis drug Vimovo is now available in nine global markets and it generated second-quarter revenue of $6.3 million — more than double Vimovo’s sales in the first quarter of this year. But Chapel Hill, North Carolina-based Pozen (NASDAQ:POZN) believes that sales for the drug that it developed with drug partner AstraZeneca (NYSE:AZN) are not […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
How can social media inform pharmaceutical sales strategies and marketing? One North Carolina pharmaceutical company is about to find out. Pozen (NASDAQ:POZN) has assembled a new digital advisory board whose members include several executives who have never marketed a drug in their lives. But Pozen hopes that the experience they bring from companies such as […]
North Carolina pharmaceutical company Pozen (NASDAQ:POZN) has named an AstraZeneca (NYSE:AZN) veteran to its board of directors, a key move as the company prepares to take a product to market on its own for the first time. Martin Nicklasson‘s experience spans both large and small pharmaceutical companies. At AstraZeneca, Nicklasson held various executive positions from […]